in order to clarify the role of the kallikrein-kinin system in the hypotensive mechanisms of converting-enzyme inhibition , captopril was administered in a single oral dose of 50 mg to 17 hypertensive patients , of whom 14 had essential hypertension , one had chronic renal failure , one had primary aldosteronism , and one had glucocorticoid responsive hyperaldosteronism .
C0006938
captopril
C0020428
hyperaldosteronism